Huakang Biomedical Holdings Company Limited, an investment holding company, engages in the research, production, and sale of male fertility in-vitro diagnostic (IVD) reagents in the People's Republic of China. The company provides biological reagents, including male fertility IVD reagents, parasite antibody detection reagents, and Epstein-Barr virus antibody detection reagent; and auxiliary reproductive supplies and equipment. The company sells its products directly to hospitals and medical institutions, as well as to distributors. Huakang Biomedical Holdings Company Limited was founded in 1992 and is based in Tsim Sha Tsui, Hong Kong.
Metrics to compare | 8622 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship8622PeersSector | |
---|---|---|---|---|
P/E Ratio | −42.4x | −23.1x | −0.5x | |
PEG Ratio | −1.10 | 0.03 | 0.00 | |
Price/Book | 3.3x | 1.8x | 2.6x | |
Price / LTM Sales | 6.9x | 6.1x | 3.3x | |
Upside (Analyst Target) | - | 2.5% | 43.3% | |
Fair Value Upside | Unlock | 2.8% | 6.9% | Unlock |